Long COVID and Your Gut: When Bloating Started After Infection

Michael Eisenwasser 8 min read

You had COVID. You recovered from the cough and the fatigue, mostly. But something in your gut never went back to normal. Bloating after meals you used to eat fine. Cramping that wasn't there before. Stool patterns that flipped. Food sensitivities you didn't have at 30.

You're not imagining it, and you're not alone. Post-infectious IBS after COVID is a well-studied pattern at this point, and the numbers are not small. If your gut went sideways after a 2020 to 2022 infection and stayed that way, there's a plausible mechanism behind it and a reasonable plan for what to try.

This post walks through what the research actually shows, where low-FODMAP fits in, and what's worth tracking before you commit to a diet change.

The short version

A meaningful share of people who had COVID developed new or worsened IBS-type symptoms afterward. A 2023 meta-analysis by Marasco and colleagues pooled ten studies covering 2,763 COVID patients and found post-COVID IBS in roughly 12 percent of them (Marasco et al., 2023). Other prospective cohort data has shown higher rates of functional GI disorders in COVID patients than in controls at six and twelve months out (BMC Infectious Diseases, 2023).

Low-FODMAP isn't a cure for long COVID. It can't undo the infection and it doesn't treat fatigue, brain fog, or the respiratory pieces. But if your main residual problem is gut symptoms that look like IBS, the low-FODMAP diet is one of the few interventions with strong evidence for that symptom pattern, regardless of what triggered the IBS in the first place.

Post-infectious IBS is not new. COVID just made it common.

Doctors have recognized post-infectious IBS for decades. The pattern is familiar: a person gets a stomach bug, a foodborne infection, a viral illness, or a course of antibiotics, and months later their gut still hasn't settled. Rates of post-infectious IBS after ordinary gastroenteritis are commonly reported somewhere in the 5 to 15 percent range, depending on the pathogen, severity, and how long patients are followed.

What changed in 2020 is that a single pathogen reached a huge share of the population at once. When you apply a baseline post-infectious rate like that to hundreds of millions of infections, you get a lot of new IBS cases compressed into a short window. Gastroenterologists noticed it early. Research caught up.

Three mechanisms appear repeatedly in the literature:

Altered gut microbiome. COVID shifts which bacteria live in your gut and in what proportions. Some of those shifts persist long after the acute infection clears. The ecosystem that ferments what you eat is not the same one you had before.

Low-grade inflammation of the gut lining. The virus can infect gut cells directly through ACE2 receptors. Some studies have found viral RNA or proteins persisting in gut tissue in a subset of patients, and Johns Hopkins researchers have reported inflammatory signaling that continues beyond the acute infection in at least some cases (Johns Hopkins Medicine, 2024). Low-grade inflammation is one of the leading candidate mechanisms for post-infectious IBS in general.

Gut-nerve signaling changes. The enteric nervous system is the network of nerves lining your digestive tract. It talks to your brain constantly through the vagus nerve. A plausible piece of the post-COVID picture is disruption to that signaling, which would help explain why post-COVID GI symptoms often look a lot like classic gut-brain-axis IBS (gut-brain connection in IBS).

You don't need to memorize the mechanism to benefit from the treatment. You just need to know that the symptom pattern is real and that conventional IBS playbooks apply.

Low-FODMAP as a trial, not a cure

If what you have now looks like IBS, and your doctor agrees it looks like IBS, then the evidence base for low-FODMAP applies to you the same way it applies to anyone with IBS. Roughly 70 to 75 percent of people with IBS get meaningful symptom relief on a well-run low-FODMAP elimination phase. That's not specific to post-COVID IBS, but post-COVID IBS is still IBS.

A few caveats worth stating plainly.

Low-FODMAP does not treat long COVID. It doesn't help fatigue, brain fog, post-exertional malaise, or the other non-GI pieces. It treats the IBS-type symptoms. If your gut is the main daily issue, that's useful. If your gut is one of ten systems misfiring, low-FODMAP is one piece of a bigger plan and you should say so to yourself up front.

Low-FODMAP is an elimination and reintroduction protocol, not a forever diet. The elimination phase runs 2 to 6 weeks, then you systematically reintroduce FODMAP groups to find your personal triggers. Staying on strict elimination long term is not the goal and can make your microbiome worse over time.

Before starting, know what low-FODMAP isn't for. It doesn't treat celiac disease or inflammatory bowel disease, which are separate conditions with their own workups. And any red-flag symptoms (blood in stool, unexplained weight loss, fever, waking at night with pain) should be evaluated by a doctor before you make diet changes. Conditions like SIBO and histamine intolerance can also look a lot like IBS, and a clinician can help sort the picture if simple approaches don't move the needle. See IBS, SIBO, or histamine intolerance for how those patterns differ.

The Monash long-COVID fibre study

Monash University, the team that built the low-FODMAP diet, is running a separate trial looking at the opposite problem: whether adding fermentable fibre can help long-COVID symptoms like fatigue and brain fog (Monash FODMAP, Dietary Fibre for Long COVID Study).

The design: participants eat intervention foods (muffins, smoothies, porridge) containing fermentable fibre for three weeks, with stool and blood samples tracked alongside daily symptom logging. The hypothesis is that feeding gut bacteria specific fibres can shift the microbiome in ways that modulate immune function and reduce non-GI long-COVID symptoms.

Two things worth noticing. First, the Monash long-COVID trial is testing adding fibre, while the low-FODMAP diet is about reducing certain fermentable carbs. Those sound contradictory but they're treating different problems. Adding fibre for immune and fatigue endpoints is not the same project as reducing fibre fractions to calm IBS symptoms. Second, the trial is still in progress as of 2026. No results yet, and results may or may not support a general recommendation.

What this tells you: Monash is taking post-COVID gut involvement seriously enough to run a dedicated trial. It also tells you that the long-COVID story is bigger than just FODMAPs, and low-FODMAP is not being positioned as the long-COVID intervention.

What to track before you change anything

If you suspect your gut issues started with COVID, the single most useful thing you can do before starting any diet is two weeks of plain symptom and food tracking.

Write down what you eat, roughly when, and how your gut feels at a few points across the day. No diet changes yet. You're building a baseline.

Patterns you're looking for:

• Which foods reliably precede bloating or cramping, and at what portions (portions matter)
• Whether symptoms track with specific meal types (high-fibre, high-onion-and-garlic, dairy-heavy) or with stress, sleep, cycle, or exercise
• Whether you have a dominant pattern (diarrhea, constipation, mixed) or whether it shifts
• Whether non-GI long-COVID symptoms (fatigue, brain fog) worsen on days your gut is worse

Two weeks of data often reveals something obvious. Onion and garlic in every meal, a beer every night, a coffee-on-empty-stomach pattern. If the obvious answer shows up, start there before you commit to a full elimination phase.

If the obvious answer doesn't show up and gut symptoms are still disrupting your life, a structured low-FODMAP elimination phase is a reasonable next step. The FODMAP Tracker app is being built for exactly this: the food logging, threshold tracking, and reintroduction scheduling that make the diet workable without turning your life into a spreadsheet.

Realistic timelines

Most people who respond to low-FODMAP see improvement within 2 to 4 weeks of strict elimination. Some see it in the first week. If you've done 6 full weeks of clean elimination and nothing's changed, low-FODMAP probably isn't your answer and you should stop and revisit rather than push further.

Post-COVID IBS does improve over time for many people, even without intervention. Some of the prospective cohort work suggests rates of functional GI disorders do drift down across the first year or two post-infection. Doing nothing is not the same as doing nothing wrong. It's just slower, and it doesn't help you work out what foods your current gut actually tolerates.

Reintroduction is where you get your real answer: which FODMAPs you can eat, at what portions, and which ones still spark symptoms. The reintroduction phase is where the diet earns its keep.

The honest bottom line

Your gut is different than it was before the infection. The research backs that up. A well-run low-FODMAP trial is one of the better-supported things you can try for the IBS-shaped piece of it, and it's reversible: if it doesn't help, you stop. The rest of long COVID is a bigger conversation with your doctor and likely a longer road. Treat the gut piece as the part you can get traction on while the rest gets worked out.

For background on the diet itself, start with what FODMAPs are and the elimination phase guide.

Track your symptoms and discover patterns with FODMAP Tracker. Includes a database of 1,000+ foods with FODMAP ratings.